Authors: Thurlimann, B Price, KN Castiglione, M Coates, AS Goldhirsch, A Gelber, RD Forbes, J Holmberg, S Veronesi, A Bernhard, J Zahrieh, D

Citation: B. Thurlimann et al., Randomized controlled trial of ovarian function suppression plus tamoxifenversus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11-93, BREAST, 10, 2001, pp. 130-138

Authors: Coldham, I Hufton, R Price, KN Rathmell, RE Snowden, DJ Vennall, GP

Citation: I. Coldham et al., Stereoselective synthesis of pyrrolidines and pyrrolizidines by intramolecular carbolithiation, SYNTHESIS-S, (10), 2001, pp. 1523-1531

Authors: Crivellari, D Bonetti, M Castiglione-Gertsch, M Gelber, RD Rudenstam, CM Thurlimann, B Price, KN Coates, AS Hurny, C Bernhard, J Lindtner, J Collins, J Senn, HJ Cavalli, F Forbes, J Gudgeon, A Simoncini, E Cortes-Funes, H Veronesi, A Fey, M Goldhirsch, A

Citation: D. Crivellari et al., Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII, J CL ONCOL, 18(7), 2000, pp. 1412-1422

Authors: Colleoni, M O'Neill, A Goldhirsch, A Gelber, RD Bonetti, M Thurlimann, B Price, KN Castiglione-Gertsch, M Coates, AS Lindtner, J Collins, J Senn, HJ Cavalli, F Forbes, J Gudgeon, A Simoncini, E Cortes-Funes, H Veronesi, A Fey, M Rudenstam, CM

Citation: M. Colleoni et al., Identifying breast cancer patients at high risk for bone metastases, J CL ONCOL, 18(23), 2000, pp. 3925-3935

Authors: Coldham, I Fernandez, JC Price, KN Snowden, DJ

Citation: I. Coldham et al., Intramolecular carbolithiation reactions for the preparation of azabicyclo[2.2.1] heptanes, J ORG CHEM, 65(12), 2000, pp. 3788-3795

Authors: Colleoni, M Price, KN Castiglione-Gertsch, M Gelber, RD Coates, AS Goldhirsch, A

Citation: M. Colleoni et al., Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil, LANCET, 354(9173), 1999, pp. 130-131